Associations of relative fat mass with metabolic dysfunction–associated steatotic liver disease and liver fibrosis: evidence from the U.S. NHANES 2017–2023 | Synapse
March 3, 2026Open Access
Associations of relative fat mass with metabolic dysfunction–associated steatotic liver disease and liver fibrosis: evidence from the U.S. NHANES 2017–2023
Puntos clave
Relative fat mass is linked to increased risk of metabolic dysfunction—associated steatotic liver disease and liver fibrosis.
A significant association was found, with higher relative fat mass correlating to liver health issues.
Observational analysis from the NHANES data collected between 2017 and 2023 reveals critical insights.
This highlights the need for further research on how relative fat mass impacts liver health among adults.